QBIO News and Press, Q BioMed Inc From 02/04/20

NEW YORK , Feb. 4, 2020 /PRNewswire/ --  Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that its research partner Mannin Research Inc. (Mannin) is developing new therapeutics to treat a variety of vascular diseases, including the new coronavirus w...

NEW YORK , Jan. 7, 2020 /PRNewswire/ --  Q BioMed Inc. (OTCQB: QBIO ), a commercial stage biotech company, is pleased to provide the following shareholder letter. Q BioMed's goal is to license and acquire undervalued biomedical assets in the healthcare sector. Since the Comp...

LOS ANGELES, CA / ACCESSWIRE / December 24, 2019 / Shares of Q BioMed (OTCQB:QBIO) have been rising steadily during the last few sessions after former Wall Street Journal All Star Analyst Theodore R. O'Neill, IRC initiated sponsored coverage on the emerging commercial stage biotech devel...

NEW YORK , Nov. 26, 2019 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is announcing today that its technology research partner Mannin Research Inc. (Mannin) presented positive data on a potential new treatment for acute kidney injury (AKI). The dat...

These 5 Penny Stocks Are Up Big But Are They Still A Buy? Most of the big markets like the S&P 500, Dow, and Nasdaq were down on November 21st. But this doesn’t mean you can’t make money in the stock market. When things get volatile, people start to look at some of the smalle...

November 21, 2019 Palm Beach, FL –November 21, 2019 – The U.S. Food and Drug Administration (FDA) as part of its mission, is responsible for protecting the public health by assuring the safety, effectiveness, and security of human drugs, vaccines and medical devices. The...

November 20, 2019 Palm Beach, FL – November 20, 2019 – It appears that the reign of the opioid drugs in the global pain management markets could be coming to an end. While opioids have long been the ‘best’ choice to address the pain patients suffer from var...

NEW YORK , Nov. 20, 2019 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO),  announces FDA approval of its contract manufacturer IsoTherapeutics Group LLC (ITG). ITG is now cleared to manufacture the Company's FDA approved non-opioid cancer bone pain drug Strontium-89 Chloride USP. The ...

NEW YORK , Nov. 5, 2019 /PRNewswire/ --  Q BioMed Inc. (OTCQB: QBIO ), a commercial stage biotech company, announced today that its technology partner, Mannin , has received a $7.5M grant from the German state of Saxony. Mannin is a research-stage biotechnology company focus...

NEW YORK , Oct. 3, 2019 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO ), a commercial stage biotech company, announced today it has entered into an exclusive distribution agreement for its non-opioid metastatic cancer pallion drug, Strontium-89 Chloride Injection USP (Strontium-89)/Me...